Skip to Content

Kamada Ltd KMDA

Morningstar Rating
$5.09 −0.01 (0.20%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

KMDA is trading at a 24% discount.
Price
$5.12
Fair Value
$5.84
Uncertainty
High
1-Star Price
$9.24
5-Star Price
$4.46
Economic Moat
Pxwk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if KMDA is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$5.10
Day Range
$5.015.12
52-Week Range
$4.086.53
Bid/Ask
$5.10 / $5.72
Market Cap
$292.57 Mil
Volume/Avg
5,342 / 22,019

Key Statistics

Price/Earnings (Normalized)
27.46
Price/Sales
1.92
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
378

Comparables

Valuation

Metric
KMDA
002007
VIR
Price/Earnings (Normalized)
27.4626.65
Price/Book Value
1.233.100.69
Price/Sales
1.926.5727.61
Price/Cash Flow
12.1318.05
Price/Earnings
KMDA
002007
VIR

Financial Strength

Metric
KMDA
002007
VIR
Quick Ratio
1.558.68
Current Ratio
3.439.05
Interest Coverage
7.04
Quick Ratio
KMDA
002007
VIR

Profitability

Metric
KMDA
002007
VIR
Return on Assets (Normalized)
2.91%−20.03%
Return on Equity (Normalized)
4.88%−25.63%
Return on Invested Capital (Normalized)
4.71%−28.31%
Return on Assets
KMDA
002007
VIR
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRSdhvzjbwNtvqhg$71.2 Bil
ZTS
Zoetis Inc Class AKjbldfvydvMkv$68.3 Bil
HLN
Haleon PLC ADRBgwhmftyBng$37.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRByvtczswFhctj$14.5 Bil
VTRS
Viatris IncYsxmdyjzdQyyb$13.4 Bil
RDY
Dr Reddy's Laboratories Ltd ADRBqcnfybZdsv$11.9 Bil
CTLT
Catalent IncDyzvtbbGhdlkw$10.1 Bil
PRGO
Perrigo Co PLCTpyqgxbbTzn$4.1 Bil
CURLF
Curaleaf Holdings IncZssbmdffHjg$3.6 Bil
PBH
Prestige Consumer Healthcare IncTlqdmrkgxKsnyrr$3.5 Bil

Sponsor Center